D
ALX Oncology Holdings Inc. ALXO
$2.11 -$0.07-3.21% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -20.68% 31.22% 13.50% -18.82% -5.80%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -43.47% -15.74% -36.25% -38.87% 12.91%
Operating Income 43.47% 15.74% 36.25% 38.87% -12.91%
Income Before Tax 34.14% 13.57% 35.87% 39.78% -15.34%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 34.14% 13.57% 35.87% 39.78% -15.34%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 34.14% 13.57% 35.87% 39.78% -15.34%
EBIT 43.47% 15.74% 36.25% 38.87% -12.91%
EBITDA 43.63% 15.82% 36.43% 39.05% -12.95%
EPS Basic 36.13% 18.81% 40.49% 52.98% 9.05%
Normalized Basic EPS 43.95% 18.82% 40.48% 52.98% 9.04%
EPS Diluted 35.53% 18.81% 40.49% 52.98% 9.05%
Normalized Diluted EPS 43.95% 18.82% 40.48% 52.98% 9.04%
Average Basic Shares Outstanding 3.11% 6.46% 7.77% 28.06% 26.80%
Average Diluted Shares Outstanding 3.11% 6.46% 7.77% 28.06% 26.80%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --